Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Citations Over TimeTop 10% of 2015 papers
Abstract
Invasion of surrounding normal tissues is generally considered to be a key hallmark of malignant (as opposed to benign) tumors. For some cancers in particular (e.g., brain tumors such as glioblastoma multiforme and squamous cell carcinoma of the head and neck - SCCHN) it is a cause of severe morbidity and can be life-threatening even in the absence of distant metastases. In addition, cancers which have relapsed following treatment unfortunately often present with a more aggressive phenotype. Therefore, there is an opportunity to target the process of invasion to provide novel therapies that could be complementary to standard anti-proliferative agents. Until now, this strategy has been hampered by the lack of robust, reproducible assays suitable for a detailed analysis of invasion and for drug screening. Here we provide a simple micro-plate method (based on uniform, self-assembling 3D tumor spheroids) which has great potential for such studies. We exemplify the assay platform using a human glioblastoma cell line and also an SCCHN model where the development of resistance against targeted epidermal growth factor receptor (EGFR) inhibitors is associated with enhanced matrix-invasive potential. We also provide two alternative methods of semi-automated quantification: one using an imaging cytometer and a second which simply requires standard microscopy and image capture with digital image analysis.
Related Papers
- → Kinetics of Hepatocyte Spheroid Formation(1994)66 cited
- → Growth and characterization of multicellular tumor spheroids of human bladder carcinoma origin(1986)16 cited
- → Incorporation of Gelatin Microspheres into HepG2 Human Hepatocyte Spheroids for Functional Improvement through Improved Oxygen Supply to Spheroid Core(2020)4 cited
- → Bio Rapid Prototyping Project: Development of Spheroid Formation System for Regenerative Medicine(2013)2 cited
- Bio Rapid Prototyping Project: Development of Spheroid Formation System for Regenerative Medicine.(2013)